Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-26 Davis J. E. EVP, General Diagnostics Shares withheld for taxes −1,432 $87.84 $126K 40,096
2019-02-26 Cunningham Everett SVP, Commercial Shares withheld for taxes −1,112 $87.84 $98K 39,755
2019-02-26 Cunningham Everett SVP, Commercial Sale −352 $87.06 $31K 39,403
2019-02-25 RUSCKOWSKI STEPHEN H Chairman, President and CEO Shares withheld for taxes −2,318 $88.24 $205K 204,082
2019-02-25 PREVOZNIK MICHAEL E SVP & General Counsel Shares withheld for taxes −315 $88.24 $28K 42,108
2019-02-25 PREVOZNIK MICHAEL E SVP & General Counsel Sale −336 $88.23 $30K 41,772
2019-02-25 Klug Robert A VP, Corporate Controller Shares withheld for taxes −52 $88.24 $5K 5,435
2019-02-25 GUINAN MARK Executive Vice President & CFO Shares withheld for taxes −660 $88.24 $58K 62,125
2019-02-25 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −363 $88.24 $32K 22,793
2019-02-25 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Shares withheld for taxes −363 $88.24 $32K 70,590
2019-02-25 Davis J. E. EVP, General Diagnostics Shares withheld for taxes −547 $88.24 $48K 41,528
2019-02-25 Cunningham Everett SVP, Commercial Shares withheld for taxes −431 $88.24 $38K 41,193
2019-02-25 Cunningham Everett SVP, Commercial Sale −326 $88.23 $29K 40,867
2019-02-22 WILENSKY GAIL R Director Exercise or conversion +8,000 $51.55 $412K 34,604
2019-02-22 WILENSKY GAIL R Director Sale −8,000 $87.78 $702K 26,604
2019-02-22 WILENSKY GAIL R Director Exercise or conversion · Stock Options (Right to Buy) −8,000 $51.55 $412K 0
2018-03-01 Cunningham Everett SVP, Commercial Gift −491 $104.78 $51K 37,760
2011-01-31 GLAXOSMITHKLINE PLC Director Sale −15,377,600 $55.62 $855.2M 15,377,551
2011-01-31 GLAXOSMITHKLINE PLC Director Sale −15,377,551 $54.30 $835.0M 0
2009-03-19 GLAXOSMITHKLINE PLC Director Sale −230,295 $44.36 $10.2M 35,274,013

Page 50 of 52 · 1,040 trades